Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Feb 02, 2024

SELL
$135.66 - $197.02 $883,417 - $1.28 Million
-6,512 Closed
0 $0
Q4 2022

Feb 02, 2024

BUY
$118.38 - $210.04 $770,890 - $1.37 Million
6,512 New
6,512 $1.17 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tactive Advisors, LLC Portfolio

Follow Tactive Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tactive Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tactive Advisors, LLC with notifications on news.